Results 101 to 110 of about 21,670 (174)

Uso clínico del carvedilol en la hipertensión arterial [PDF]

open access: yes, 2022
El carvedilol es un agente betabloqueante ampliamente utilizado en el tratamiento de la insufciencia cardiaca. Numerosos estudios randomizados y controlados han demostrado su efcacia, seguridad y hasta su superioridad sobre otros betabloqueantes ...
Diaz, Alejandro
core  

Substituição do carvedilol pelo propranolol em pacientes com insuficiência cardíaca Sustitución del carvedilol por el propranolol en pacientes con insuficiencia cardíaca Replacement of carvedilol for propranolol in patients with heart failure

open access: yesArquivos Brasileiros de Cardiologia, 2010
FUNDAMENTO: Grandes estudos clínicos empregando os betabloqueadores carvedilol, metoprolol, bisoprolol e nebivolol, demonstraram melhora da sobrevida e dos sintomas em pacientes com insuficiência cardíaca.
Fabiana Marques   +6 more
doaj  

Prevention of Skin Carcinogenesis by the b-Blocker Carvedilol

open access: yes, 2020
The stress-related catecholamine hormones and the a-and b-adrenergic receptors (a-and b-AR) may affect carcinogenesis. The b-AR GRK/b-arrestin biased agonist carvedilol can induce b-AR-mediated transactivation of the EGFR.
Mandy M Liu   +10 more
core  

Carvedilol vs endoscopic band ligation for the prevention of variceal bleeding: a meta-analysis

open access: yes, 2019
Shan Tian,1,* Ruixue Li,2,* Yingyun Guo,1 Xuemei Jia,1 Weiguo Dong1 1Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of China; 2Department of Gastroenterology, Renmin Hospital of Macheng City ...
Dong W, Guo Y, Tian S, Jia X, Li R
core  

Skin Cancer Prevention by Carvedilol

open access: yes, 2015
Since approximately 90 percent of diagnosed non-melanoma skin cancers are associated with exposure to ultraviolet (UV) radiation from the sun, the primary form being UVB irradiation, we hypothesized that carvedilol will prevent UVB-induced skin ...
Huang, Kevin M.
core  

The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis

open access: yes, 2015
Sheng Chen,1,* Jin-Jun Wang,2,* Qin-Qin Wang,1 Jun-Wei Hu,1 Shuang Dong,1 Li-Juan Hu,1 Yi-Cheng Jian,1 Xin-Yan Liu,2 Gen-Mei Yang,2 Wu-Jun Xiong1 1Department of Hepatology, Tongji University School of Medicine, Shanghai East Hospital, 2Department of ...
Xiong WJ   +9 more
core  

Carvedilol induces greater control of β2- than β1-adrenoceptor-mediated inotropic and lusitropic effects by PDE3, while PDE4 has no effect in human failing myocardium

open access: yes, 2014
The β-blockers carvedilol and metoprolol provide important therapeutic strategies for heart failure treatment. Therapy with metoprolol facilitates the control by phosphodiesterase PDE3, but not PDE4, of inotropic effects of catecholamines in human ...
Galindo-Tovar, Alejandro   +9 more
core   +1 more source

Dose of carvedilol at each follow-up.

open access: yes, 2018
Among 394 patients in the carvedilol group, 12 patients did not receive the assigned carvedilol treatment; prescription of bisoprolol in 7 patients and no prescription of beta-blocker in 5 patients (protocol violation).
Kazushige Kadota (665891)   +26 more
core   +1 more source

Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction

open access: yes, 2008
William H Frishman1, Linda S Henderson2, Mary Ann Lukas21Departments of Medicine and Pharmacology, New York Medical College/Westchester Medical Center, Valhalla, NY, USA; 2Cardiovascular and Metabolic Medicine Development Center, GlaxoSmithKline ...
Linda S Henderson   +2 more
core  

Carvedilol in glioma treatment alone and with imatinib in vitro

open access: yes, 2010
The purpose of the study was to investigate whether carvedilol has an antiproliferative effect alone and whether carvedilol provides an additive, synergistic or antagonistic effect on imatinib mesylate-induced cytotoxicity in both C6 glioma monolayer and
Erguven, Mine   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy